VYNE Therapeutics (VYNE) P/E (2018 - 2026)
VYNE Therapeutics (VYNE) P/E from Jan 25, 2018 to Jul 21, 2026. The TTM VYNE Therapeutics (VYNE) P/E is -0.51. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of VYNE Therapeutics (VYNE)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.51 | +117.00% |
| 2025 | -0.24 | -80.90% |
| 2024 | -1.23 | +420.89% |
| 2023 | -0.24 | -55.49% |
| 2022 | -0.53 | -81.78% |
| 2021 | -2.92 | +7.72% |
| 2020 | -2.71 | -49.90% |
| 2019 | -5.40 | +7.48% |
| 2018 | -5.03 | N/A |
Comparison VYNE Therapeutics (VYNE) P/E with competitors
VYNE Therapeutics (VYNE) P/E is -0.51.